PFM Health Sciences’s Danaher DHR Stock Holding History

PFM Health Sciences’s Portfolio DHR Stock Details DHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-161,413	Closed	-$31.9M	–	77
2025 Q2	$31.9M	Buy	161,413 +48,938	+44%	+$9.49M	2.71%	11
2025 Q1	$23.1M	Sell	112,475 -13,040	-10%	-$2.85M	1.67%	21
2024 Q4	$28.8M	Hold	125,515	–	–	1.79%	17
2024 Q3	$34.9M	Hold	125,515	–	–	1.98%	16
2024 Q2	$31.4M	Hold	125,515	–	–	1.55%	23
2024 Q1	$31.3M	Hold	125,515	–	–	1.47%	25
2023 Q4	$29M	Sell	125,515 -72,663	-37%	-$15.5M	1.74%	20
2023 Q3	$43.6M	Hold	198,178	–	–	2.05%	20
2023 Q2	$42.2M	Hold	198,178	–	–	1.64%	27
2023 Q1	$44.3M	Hold	198,178	–	–	1.96%	17
2022 Q4	$46.6M	Hold	198,178	–	–	1.67%	22
2022 Q3	$45.4M	Hold	198,178	–	–	1.64%	22
2022 Q2	$44.5M	Hold	198,178	–	–	1.7%	20
2022 Q1	$51.5M	Hold	198,178	–	–	1.93%	17
2021 Q4	$57.8M	Hold	198,178	–	–	1.97%	16
2021 Q3	$53.5M	Hold	198,178	–	–	1.57%	25
2021 Q2	$47.1M	Hold	198,178	–	–	1.48%	24
2021 Q1	$39.5M	Buy	198,178 +5,006	+3%	+$1.02M	1.21%	29
2020 Q4	$38M	Buy	193,172 +8,560	+5%	+$1.72M	1.34%	30
2020 Q3	$35.2M	Sell	184,612 -9,766	-5%	-$1.74M	1.63%	20
2020 Q2	$30.5M	Buy	+194,378	New	+$27.9M	1.58%	25

Other funds holding DHR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PFM Health Sciences's DHR Position: Q3 2025 in Review

PFM Health Sciences sold out of Danaher (DHR) in Q3 2025, closing a stake of 161,413 shares — an estimated $31.9M sold.

PFM Health Sciences first reported a position in DHR in Q2 2020 and held it in 21 quarters. The position peaked at $57.8M in Q4 2021. 2,147 funds tracked by Wall St. Rank hold DHR as of Q3 2025.

PFM Health Sciences reported no remaining Danaher position as of Q3 2025 after selling out during the quarter.
PFM Health Sciences sold 161,413 Danaher shares in Q3 2025, an estimated $31.9M.
PFM Health Sciences first reported a position in Danaher in Q2 2020 and held it in 21 quarters.
PFM Health Sciences's Danaher position peaked at $57.8M in Q4 2021.
2,147 funds tracked by Wall St. Rank held Danaher as of Q3 2025.

Based on PFM Health Sciences's 13F filing for Q3 2025, filed 14 Nov 2025.